Joseph Baar
Hematology & Oncology · Cleveland, OHNPI 1346269230
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 58.2% of the total. Reporting peaked in 2019 at $4,186 and has fallen 97.4% since, to $107 in 2022.
Across 23 payments — averaging $311.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$4K
- Merck$3K
- Sanofi$41
- Amgen$41
- Epizyme, Inc.$28
- AVEO Pharmaceuticals, Inc.$20
- plus $117 from 8 others
Across 33 payments — averaging $57,149 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.1M
- Novartis$731K
- Daiichi Sankyo Inc.$81K
What the payments were for
- Consulting fees$3,09043%
- Speaking & faculty fees$2,75038%
- Travel & lodging$90713%
- Food & beverage$4056%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 7 | $4,167 |
| Merck | 1 | $2,750 |
| Sanofi | 2 | $41 |
| Amgen | 2 | $41 |
| Epizyme, Inc. | 2 | $28 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Novartis | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Gilead | 1 | $12 |
| Beigene USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$2,750
How this compares
$7,164 in reported general payments places this provider in the 65th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Cleveland
- Hillard LazarusCleveland$2M
- Ronald BukowskiCleveland$594K
- Balazs HalmosCleveland$568K
- Jorge GarciaCleveland$513K
- Bachar DerghamCleveland$387K
- Brian HillCleveland$316K
- Dale ShepardCleveland$314K
- Sakti ChakrabartiCleveland$301K
- Keith McCraeCleveland$215K
- Megan KruseCleveland$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.